KR20030019951A - 변비가 없는 남성 과민성대장증후군 환자의 치료를 위한실란세트론 함유 의약 - Google Patents

변비가 없는 남성 과민성대장증후군 환자의 치료를 위한실란세트론 함유 의약 Download PDF

Info

Publication number
KR20030019951A
KR20030019951A KR10-2003-7000038A KR20037000038A KR20030019951A KR 20030019951 A KR20030019951 A KR 20030019951A KR 20037000038 A KR20037000038 A KR 20037000038A KR 20030019951 A KR20030019951 A KR 20030019951A
Authority
KR
South Korea
Prior art keywords
silanesetron
patients
bowel syndrome
irritable bowel
use according
Prior art date
Application number
KR10-2003-7000038A
Other languages
English (en)
Korean (ko)
Inventor
베르너 카우트릴스
클라우스 루돌프 스타인본
하인쯔 귄터 크라우제
스티븐 데이빗 카라스
에그베투스 헨드리쿠스 에버트 비세우벨
알베르투스 헤르마누스 디크 플레켄폴
Original Assignee
솔베이 파머슈티컬스 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 솔베이 파머슈티컬스 게엠베하 filed Critical 솔베이 파머슈티컬스 게엠베하
Priority claimed from PCT/EP2001/008260 external-priority patent/WO2002007713A2/de
Publication of KR20030019951A publication Critical patent/KR20030019951A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR10-2003-7000038A 2000-07-26 2001-07-18 변비가 없는 남성 과민성대장증후군 환자의 치료를 위한실란세트론 함유 의약 KR20030019951A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10036645 2000-07-26
DE10036645.7 2000-07-26
DE10123447.3 2001-05-14
DE10123447A DE10123447A1 (de) 2000-07-26 2001-05-14 Cilansetron enthaltende Arzneimittel zur Behandlung nicht-obstipativer männlicher IBS-Patienten
PCT/EP2001/008260 WO2002007713A2 (de) 2000-07-26 2001-07-18 Cilansetron enthaltende arzneimittel zur behandlung nicht-obstipativer männlicher ibs-patienten

Publications (1)

Publication Number Publication Date
KR20030019951A true KR20030019951A (ko) 2003-03-07

Family

ID=7650430

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7000038A KR20030019951A (ko) 2000-07-26 2001-07-18 변비가 없는 남성 과민성대장증후군 환자의 치료를 위한실란세트론 함유 의약

Country Status (2)

Country Link
KR (1) KR20030019951A (de)
DE (1) DE10123447A1 (de)

Also Published As

Publication number Publication date
DE10123447A1 (de) 2002-02-07

Similar Documents

Publication Publication Date Title
TW576743B (en) Extended release formulations of erythromycin derivatives
RO115780B1 (ro) Combinatie sinergica
US4210670A (en) Antithrombotic agents
Bayley et al. Nifedipine in the treatment of hypertension: report of a double‐blind controlled trial.
JP3018160B2 (ja) 月経困難症及び／又は月経前症候群の軽減用薬剤
US6566369B2 (en) Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients
US6613768B1 (en) Treatment of female arousal disorder
KR20060052661A (ko) 설사-우세형 과민성 대장 증후군의 치료제
Naclerio The effect of antihistamines on the immediate allergic response: a comparative review
US7683090B2 (en) Treating agent for irritable bowel syndrome
KR100692235B1 (ko) 안지오텐신 ⅱ 길항물질의 신규한 용도
AU2002254947B2 (en) Kappa opiate agonists for the treatment of bladder diseases
MXPA02012917A (es) Medicamentos que contienen cilansetron para el tratamiento de pacientes de ibs masculinos no estre°idos.
NL8002041A (nl) Werkwijze voor het bereiden van een analgetisch en myotonolytisch geneesmiddel.
SK125998A3 (en) Use of metoclopramide
KR20030019951A (ko) 변비가 없는 남성 과민성대장증후군 환자의 치료를 위한실란세트론 함유 의약
KR101978459B1 (ko) 조루증 치료용 약학 조성물 및 조루증 치료 방법
US20060079513A1 (en) Methods and compositions including methscopolamine nitrate
BG63103B1 (bg) Използуване на алендронат за профилактика на остеопороза
KR20180037408A (ko) 락티톨을 포함하는 과민성 대장 증후군 예방 및 치료용 약학적 조성물
US20060079514A1 (en) Methods and compositions including methscopolamine bromide
US7842702B2 (en) Treatment for irritable bowel syndrome
Bakshi et al. Efficacy and tolerability of diclofenac dispersible in elderly patients with osteoarthritis
CA2516433C (en) Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome
JPH0812576A (ja) 抗ヘリコバクター・ピロリ剤

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid